Literature DB >> 12629277

Atrial fibrillation is associated with severe acute ischemic stroke.

Douglas A Dulli1, Heather Stanko, Ross L Levine.   

Abstract

Atrial fibrillation (AF) is a common risk factor for disabling ischemic stroke in the elderly, but it is not clear that its severity is generally worse than that of ischemic stroke due to other etiologies. We reviewed the clinical presentations of patients with acute ischemic stroke admitted between 1990 and 2001. The etiologies of these strokes were also classified using well-established criteria. Of 1,061 patients with acute ischemic stroke, 216 (20.3%) had AF. The frequency of bedridden state was 41.2% in patients with AF, compared to 23.7% in patients without AF (p < 0.0005). Other measures of clinical stroke severity showed similar disparities between these groups. The odds ratio for bedridden state following ischemic stroke due to AF was 2.23 (95% CI = 1.87-2.59, p < 0.0005) by multivariate logistic regression. Ischemic stroke associated with AF is typically more severe than ischemic stroke due to other etiologies, and this increased severity is independent of advanced age and other stroke risk factors. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629277     DOI: 10.1159/000068743

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  62 in total

1.  Contemporary approaches to managing atrial fibrillation: A survey of Australian general practitioners.

Authors:  Beata Bajorek; Parker Magin; Sarah Hilmer; Ines Krass
Journal:  Australas Med J       Date:  2015-11-30

Review 2.  Assessment and impact of cardiac fibrosis on atrial fibrillation.

Authors:  Nazem Akoum; Nassir Marrouche
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  Comment on the European guidelines for the management of atrial fibrillation.

Authors:  Samir M Said; Ruediger C Braun-Dullaeus
Journal:  Clin Res Cardiol       Date:  2011-01-11       Impact factor: 5.460

Review 4.  Dabigatran, A Direct Thrombin Inhibitor, In Atrial Fibrillation: Is It Already Time For A Change In Oral Anticoagulation Therapy?

Authors:  Osmar Antonio Centurión
Journal:  J Atr Fibrillation       Date:  2010-01-01

5.  Neurologic symptom severity after a recent noncardioembolic stroke and recurrent vascular risk.

Authors:  Jong-Ho Park; Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-03-25       Impact factor: 2.136

Review 6.  New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?

Authors:  Peter J Kudenchuk
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

7.  Heart failure in acute ischemic stroke.

Authors:  Angel Ois; Meritxell Gomis; Elisa Cuadrado-Godia; Jordi Jiménez-Conde; Ana Rodríguez-Campello; Jordi Bruguera; Lluis Molina; Josep Comin; Jaume Roquer
Journal:  J Neurol       Date:  2008-03-19       Impact factor: 4.849

8.  An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality.

Authors:  Etienne Aliot; Günter Breithardt; Josep Brugada; John Camm; Gregory Y H Lip; Panos E Vardas; Markus Wagner
Journal:  Europace       Date:  2010-05       Impact factor: 5.214

9.  Atrial fibrillation in patients with ischemic stroke: A population-based study.

Authors:  Sandra Kruchov Thygesen; Lars Frost; Kim A Eagle; Søren Paaske Johnsen
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

10.  Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.

Authors:  Axel Brandes; Mikkel Overgaard; Liane Plauborg; Christian Dehlendorff; Frede Lyck; Jørgen Peulicke; Søren Vinther Poulsen; Steen Husted
Journal:  Clin Cardiol       Date:  2013-05-13       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.